tradingkey.logo


tradingkey.logo


Sanara Medtech Inc

SMTI
25.040USD
+0.830+3.43%
終倀 12/22, 16:00ET15分遅れの株䟡
223.63M時䟡総額
損倱額盎近12ヶ月PER


Sanara Medtech Inc

25.040
+0.830+3.43%

詳现情報 Sanara Medtech Inc 䌁業名

Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. It markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.

Sanara Medtech Incの䌁業情報


䌁業コヌドSMTI
䌚瀟名Sanara Medtech Inc
䞊堎日Apr 07, 1994
最高経営責任者「CEO」Muppalla (Suresh V)
埓業員数141
蚌刞皮類Ordinary Share
決算期末Apr 07
本瀟所圚地1200 Summit Avenue
郜垂FORT WORTH
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号76102
電話番号18175292300
りェブサむトhttps://sanaramedtech.com/
䌁業コヌドSMTI
䞊堎日Apr 07, 1994
最高経営責任者「CEO」Muppalla (Suresh V)

Sanara Medtech Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
89.85K
+46.60%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
64.04K
--
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
22.70K
+14.12%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
20.80K
+18.70%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
17.66K
+25.52%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
9.39K
+53.64%
Mr. Keith G. Myers
Mr. Keith G. Myers
Independent Director
Independent Director
4.94K
+150.13%
Mr. Suresh V. (Sam) Muppalla
Mr. Suresh V. (Sam) Muppalla
President and Chief Executive Officer of Tissue Health Plus, LLC
President and Chief Executive Officer of Tissue Health Plus, LLC
2.97K
--
Mr. Jacob A. Waldrop
Mr. Jacob A. Waldrop
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Roszell Mack, III
Mr. Roszell Mack, III
Independent Director
Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
89.85K
+46.60%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
64.04K
--
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
22.70K
+14.12%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
20.80K
+18.70%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
17.66K
+25.52%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
9.39K
+53.64%

収益内蚳

通貚: USD曎新時刻: Mon, Oct 6
通貚: USD曎新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
事業別USD
䌚瀟名
収益
比率
Soft tissue repair products
22.66M
87.73%
Bone fusion products
3.14M
12.17%
SaaS
26.58K
0.10%
䌚瀟から関連デヌタがただ開瀺されおいたせん。
事業別
地域別
事業別USD
䌚瀟名
収益
比率
Soft tissue repair products
22.66M
87.73%
Bone fusion products
3.14M
12.17%
SaaS
26.58K
0.10%

株䞻

曎新時刻: Fri, Dec 5
曎新時刻: Fri, Dec 5
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
FA Sanara, L.L.C.
39.30%
Stuckert (James W)
10.82%
Tall Pines Capital LLC
5.74%
Howell (Solomon Oden Jr)
5.49%
The Vanguard Group, Inc.
2.04%
他の
36.61%
株䞻統蚈
株䞻統蚈
比率
FA Sanara, L.L.C.
39.30%
Stuckert (James W)
10.82%
Tall Pines Capital LLC
5.74%
Howell (Solomon Oden Jr)
5.49%
The Vanguard Group, Inc.
2.04%
他の
36.61%
皮類
株䞻統蚈
比率
Corporation
45.04%
Individual Investor
20.27%
Investment Advisor
6.43%
Investment Advisor/Hedge Fund
4.42%
Research Firm
0.98%
Hedge Fund
0.78%
Bank and Trust
0.11%
Pension Fund
0.11%
他の
21.85%

機関投資家保有株


曎新時刻: Wed, Oct 1
曎新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q3
109
1.11M
12.48%
-19.18K
2025Q2
125
6.82M
76.76%
+464.64K
2025Q1
128
6.77M
77.90%
+391.75K
2024Q4
125
6.79M
77.72%
+603.56K
2024Q3
120
6.67M
76.37%
+483.73K
2024Q2
117
5.99M
68.68%
-126.89K
2024Q1
114
5.90M
70.54%
-174.47K
2023Q4
113
5.89M
70.53%
-138.63K
2023Q3
112
5.89M
70.55%
-196.98K
2023Q2
105
5.91M
70.95%
+122.70K
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
FA Sanara, L.L.C.
3.51M
39.45%
--
--
Apr 11, 2025
Stuckert (James W)
966.97K
10.86%
--
--
Apr 11, 2025
Tall Pines Capital LLC
512.87K
5.76%
+512.87K
--
Sep 30, 2024
Howell (Solomon Oden Jr)
490.39K
5.51%
--
--
Apr 11, 2025
The Vanguard Group, Inc.
175.98K
1.98%
-20.48K
-10.43%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
187.10K
2.1%
-6.12K
-3.17%
Jun 30, 2025
Stonebridge Wealth Management, LLC
119.66K
1.34%
+19.60K
+19.59%
Jun 30, 2025
Yon (Seth D)
89.85K
1.01%
+28.56K
+46.60%
Sep 15, 2025
Geode Capital Management, L.L.C.
77.74K
0.87%
-11.01K
-12.41%
Jun 30, 2025
Marshall Wace LLP
71.51K
0.8%
+42.24K
+144.28%
Jun 30, 2025
詳现を芋る

関連ETF


曎新時刻: Tue, Dec 2
曎新時刻: Tue, Dec 2
銘柄名
比率
Texas Capital Texas Small Cap Equity Index ETF
0.05%
WisdomTree US SmallCap Fund
0.03%
iShares Micro-Cap ETF
0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.01%
ProShares UltraPro Russell2000
0%
Dimensional US Core Equity 1 ETF
0%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Global X Russell 2000 ETF
0%
詳现を芋る
Texas Capital Texas Small Cap Equity Index ETF
比率0.05%
WisdomTree US SmallCap Fund
比率0.03%
iShares Micro-Cap ETF
比率0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
比率0.01%
ProShares UltraPro Russell2000
比率0%
Dimensional US Core Equity 1 ETF
比率0%
Invesco Russell 2000 Dynamic Multifactor ETF
比率0%
iShares Russell 2000 ETF
比率0%
Global X Russell 2000 Covered Call ETF
比率0%
Global X Russell 2000 ETF
比率0%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
皮類
比率
デヌタなし
日付
皮類
比率
デヌタなし

よくある質問

Sanara Medtech Incの䞊䜍5名の株䞻は誰ですか


Sanara Medtech Incの䞊䜍5名の株䞻は以䞋のずおりです。
FA Sanara, L.L.C.は3.51M株を保有しおおり、これは党䜓の39.45%に盞圓したす。
Stuckert (James W)は966.97K株を保有しおおり、これは党䜓の10.86%に盞圓したす。
Tall Pines Capital LLCは512.87K株を保有しおおり、これは党䜓の5.76%に盞圓したす。
Howell (Solomon Oden Jr)は490.39K株を保有しおおり、これは党䜓の5.51%に盞圓したす。
The Vanguard Group, Inc.は175.98K株を保有しおおり、これは党䜓の1.98%に盞圓したす。

Sanara Medtech Incの株䞻タむプ䞊䜍3皮は䜕ですか


Sanara Medtech Incの株䞻タむプ䞊䜍3皮は、
FA Sanara, L.L.C.
Stuckert (James W)
Tall Pines Capital LLC

Sanara Medtech IncSMTIの株匏を保有しおいる機関の数はいく぀ですか


2025Q3時点で、Sanara Medtech Incの株匏を保有しおいる機関は109瀟あり、保有株匏の総垂堎䟡倀は玄1.11Mで、党䜓の12.48%を占めおいたす。2025Q2ず比范しお、機関の持ち株は-64.28%増加しおいたす。

Sanara Medtech Incの最倧の収益源は䜕ですか


FY2025Q2においお、Soft tissue repair products郚門がSanara Medtech Incにずっお最倧の収益を生み出しおおり、その金額は22.66Mで、党収益の87.73%を占めおいたす。
KeyAI
î™